This is an info Alert.
  • Home
  • Product
  • Blog
  • Contact

Discover laboratory and life science products for your research. Search our catalog by product name, keyword or catalog number and find the right solution for your laboratory.

Search thousands of research products

Product information & research resources

Support for your product inquiries

Products
All productsSearch products
Resources
ArticlesFAQs
Company
About usContact us
Legal
Terms & conditionsPrivacy policy

© 2026 Gentaur. All rights reserved.
ProductsArticlesContact
0
  1. Home
  2. Products
  3. Ionotropic glutamate receptor 2 + 3 Recombinant Rabbit Monoclonal Antibody [JE33-28]
1/0

Ionotropic glutamate receptor 2 + 3 Recombinant Rabbit Monoclonal Antibody [JE33-28]

Product ID: 873688087893


Gentaur Catalog Number

GTR09936212
Select size

100 µL

$726.85
​
Selected
100 µL

$726.85

1

Glutamate ionotropic receptor AMPA type subunit 2 (Glutamate receptor 2, or GluR-2) is a protein that in humans is encoded by the GRIA2 (or GLUR2) gene and it is a subunit found in the AMPA receptors. Glutamate receptor 3 is a protein that in humans is encoded by the GRIA3 gene. Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. GRIA2 product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), called AMPA receptors, and function as ligand-activated cation channels. These channels are assembled from a combination of 4 subunits, encoded by 4 genes (GRIA1-4). The subunit encoded by this gene (GRIA2) is subject to RNA editing which renders the receptor that it becomes part of impermeable to calcium ions (Ca2+). Human and animal studies suggest that the RNA editing is essential for normal brain function, and defective RNA editing of GRIA2 may be relevant to the etiology of amyotrophic lateral sclerosis (ALS). Alternative splicing, resulting in transcript variants encoding different isoforms, has been noted for GRIA2, which includes the generation of flip and flop isoforms that vary in their signal transduction properties. Genome studies have uncovered a tentative link between defective GRIA3 variants and a highly elevated risk of schizophrenia.